Research uncovers how P-stalk ribosomes regulate cytokine responses, driving immune evasion in tumors across multiple cancer ...

Ludwig Cancer Research scientists have devised new types of chimeric antigen-receptor (CAR) T cells—a type of cancer ...

Ludwig Cancer Research scientists have devised new types of chimeric antigen-receptor (CAR) T cells—a type of cancer ...

given the multitude of vaccine approaches currently being tested and the even greater number of vaccine target antigens being evaluated. In a recent report by the National Cancer Institute ...

Utilizing an analytic hierarchy process (AHP) based on preidentified criteria and weighted by a panel of experts, Cheever and colleagues constructed priority rankings of 75 cancer antigens.

The Ludwig Institute for Cancer Research (LICR) maintains the "CTDatabase." [4] This database is an authoritative list of known CT antigens. It also serves as a repository into which new candidates ...

Antibody-drug conjugates (ADCs) have emerged as a promising approach in cancer therapy, offering a 'magic bullet' strategy ...

Ludwig Cancer Research scientists have developed a full, start-to-finish computational pipeline that integrates multiple ...

If prostate cancer spreads to other parts of the body, it can become deadly and commonly moves to bones, the lungs, lymph ...

Elicera Therapeutics describes how CAR T cells armed with neutrophil-activatingprotein can improve cancer therapy by inducing ...

A new study published in the Journal of American Medical Association showed that the combination of testing for H pylori ...

INT2104 is a novel in vivo chimeric antigen receptor (CAR) gene therapy designed to generate CAR-T and CAR-NK ... Michael Dickinson, MBBS, FRACP, Lead of the Aggressive Lymphoma Disease Group at Peter ...